EUVIMEDEUVIMED entdecken
Crossref

Impact of a Standardized Multidisciplinary Quality Improvement Project to Improve Clinical Outcomes in Cystic Fibrosis: A 12‐Month Phased Project at Ain Shams University

Mahitab Morsy Hussein, Samya Zaki Nasr, Terez Boshra Kamel, Mona Rashad, Dina Nabil Kamel, Eman Abdelnaeem Fawzy iD

Pediatric Pulmonology · 2026

DOI: 10.1002/ppul.71621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2026. Verfasst von Mahitab Morsy Hussein und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Pulmonology, Ain Shams University Pediatric Hospital, Cairo, Egypt. Hauptthemen laut MEDLINE: Cystic Fibrosis, Quality Improvement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In low‐resource countries, cystic fibrosis (CF) care often falls below international standards, particularly regarding pulmonary outcomes, airway clearance, nutrition, cystic fibrosis transmembrane conductance regulator (CFTR) modulator availability, and multidisciplinary care. Quality improvement (QI) methodologies provide structured approaches to address these deficiencies.

Objective

To evaluate whether a 12 months Plan‐Do‐Study‐Act (PDSA)‐driven QI intervention could yield an absolute ≥ 5% increase in mean FEV1pp among people with cystic fibrosis (PwCF) with baseline FEV1pp ≤ 80%, and to distinguish the effects of the QI interventions over 12 months in patients who did not receive elexacaftor/tezacaftor/ivacaftor (ETI) at any time during the projec period (non‐ETI group), from those in patients who initiated ETI after 6 months, in order to assess the additional impact of therapy beyond the QI interventions.

Methods

Between May 2024 and May 2025, 45 PwCF aged 6–21 years were enrolled at Ain Shams University Pediatric Hospital, Egypt, in collaboration with the University of Michigan CF Center. Sequential PDSA cycles implemented personalized airway clearance, intensified nutritional support, caregiver education, and telehealth follow‐up. The project comprised Phase 1 (0–6 months, QI‐only) and Phase 2 (6–12 months), during which 56% initiated ETI. Outcomes included FEV1pp, BMI‐for‐age Z ‐scores, status, and antibiotic use.

Results

Baseline mean age was 9.9 ± 3.5 years, mean FEV1pp 60.6 ± 16.7%, and BMI‐for‐age Z ‐score −1.05 ± 1.29. In the non‐ETI group, mean FEV1pp increased from 57.9% at baseline to 65.0% at 12 months, yielding an absolute mean gain of +7.1% ( p < 0.001), surpassing the predefined target of ≥ 5%, while mean BMI‐for‐age Z‐scores improved from −0.88 to −0.13 (+0.75; p < 0.001). ETI‐treated patients demonstrated greater improvements during phase 2, with mean FEV1pp rising from 66.4% to 78.6% (+12.2%; p < 0.001) and mean BMI Z ‐score improving from −0.64 to −0.05 (+0.59; p < 0.001). Antibiotic use declined significantly over the project period.

Conclusions

A tailored multidisciplinary QI protocol significantly improved lung function and nutrition in PwCF in a resource‐limited setting, with CFTR modulators providing additional clinically meaningful benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisQuality ImprovementHumansChildAdolescentMaleFemaleYoung AdultDrug CombinationsForced Expiratory VolumeQuinolonesTreatment OutcomePyrazoles

Stichwörter der Autor:innen

BMIFEV1Plan‐Do‐Study‐Act (PDSA) cyclescystic fibrosismultidisciplinary carequality improvement

Substanzen

Drug CombinationsQuinolonesPyrazoles

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Pulmonology, Ain Shams University Pediatric Hospital, Cairo, Egypt.
  • Department of Pediatrics, Division of Pediatric Pulmonology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Pediatrics, Division of Pediatric Endocrinology, Ain Shams University Pediatric Hospital, Cairo, Egypt.
  • Department of Community, Environmental and Occupational Medicine, Ain Shams University, Cairo, Egypt.

ORCID-Profile: Eman Abdelnaeem Fawzy

Zitieren

APA

Hussein, M. M., Nasr, S. Z., Kamel, T. B., Rashad, M., Kamel, D. N., & Fawzy, E. A. (2026). Impact of a Standardized Multidisciplinary Quality Improvement Project to Improve Clinical Outcomes in Cystic Fibrosis: A 12‐Month Phased Project at Ain Shams University. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71621

Vancouver

Hussein MM, Nasr SZ, Kamel TB, Rashad M, Kamel DN, Fawzy EA. Impact of a Standardized Multidisciplinary Quality Improvement Project to Improve Clinical Outcomes in Cystic Fibrosis: A 12‐Month Phased Project at Ain Shams University. Pediatric Pulmonology. 2026. doi:10.1002/ppul.71621

BibTeX
@article{Hussein2026,
  author = {Hussein, Mahitab Morsy and Nasr, Samya Zaki and Kamel, Terez Boshra and Rashad, Mona and Kamel, Dina Nabil and Fawzy, Eman Abdelnaeem},
  title = {Impact of a Standardized Multidisciplinary Quality Improvement Project to Improve Clinical Outcomes in Cystic Fibrosis: A 12‐Month Phased Project at Ain Shams University},
  journal = {Pediatric Pulmonology},
  year = {2026},
  doi = {10.1002/ppul.71621}
}
Kostenlos starten →